TGFB1 and breast cancer: This study examined the correlation between the expression of the receptors for the growth factor TGFβ, an inducer of EMT, and the receptor for PRL hormone, a suppressor of EMT, in relation to clinicopathological criteria and patient outcomes in breast cancer clinical cases.